Canada Preclinical Cro Market Size & Outlook, 2025-2033

The preclinical cro market in Canada is expected to reach a projected revenue of US$ 239.0 million by 2033. A compound annual growth rate of 4.6% is expected of Canada preclinical cro market from 2025 to 2033.
Revenue, 2024 (US$M)
$159.4
Forecast, 2033 (US$M)
$239.0
CAGR, 2025 - 2033
4.6%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada preclinical cro market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada preclinical cro market highlights

  • The Canada preclinical cro market generated a revenue of USD 159.4 million in 2024 and is expected to reach USD 239.0 million by 2033.
  • The Canada market is expected to grow at a CAGR of 4.6% from 2025 to 2033.
  • In terms of segment, toxicology testing was the largest revenue generating service in 2024.
  • Bioanalysis and DMPK studies is the most lucrative service segment registering the fastest growth during the forecast period.


Preclinical cro market data book summary

Market revenue in 2024USD 159.4 million
Market revenue in 2033USD 239.0 million
Growth rate4.6% (CAGR from 2025 to 2033)
Largest segmentToxicology testing
Fastest growing segmentBioanalysis and DMPK studies
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationBioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Service
Key market players worldwideEurofins Scientific SE, Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Labcorp Holdings Inc, Crown Bioscience, SGA


Other key industry trends

  • In terms of revenue, Canada accounted for 2.6% of the global preclinical cro market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In North America, U.S. preclinical cro market is projected to lead the regional market in terms of revenue in 2033.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 5,338.0 million by 2033.

Toxicology testing was the largest segment with a revenue share of 23.59% in 2024. Horizon Databook has segmented the Canada preclinical cro market based on bioanalysis and dmpk studies, toxicology testing, compound management, chemistry, safety pharmacology, others service covering the revenue growth of each sub-segment from 2021 to 2033.


The Government of Canada states that the country has one of the largest numbers of biotechnology companies globally. In addition, Health Canada, the regulatory body of Canada responsible for public health, supports and encourages investment in terms of clinical development & manufacturing of biopharmaceutical products. The country is considered a favorable location for preclinical trial outsourcing owing to high potential for R&D activities.

According to Statistics Canada, in 2022, the R&D of the pharmaceutical sector contributed USD 15.9 billion to the economy, which was an increase of 5.8% from USD 15.0 billion in 2019. Such R&D efforts undertaken by pharmaceutical companies in Canada are expected to boost the market in this region.

In addition, the country’s proximity to the U.S. is expected to provide a logistical advantage to local CROs, further contributing to the growth of the preclinical trial outsourcing market in Canada.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Preclinical CRO Market Companies

Name Profile # Employees HQ Website
SGA View profile 11-50 Las Condes, Region Metropolitana, Chile, South America https://sgasa.cl
Crown Bioscience View profile 251-500 Santa Clara, California, United States, North America http://www.crownbio.com
Intertek Group PLC View profile 44000 33 Cavendish Square, London, United Kingdom, W1G 0PS https://www.intertek.com
Medpace Holdings Inc View profile 5800 5375 Medpace Way, Cincinnati, OH, United States, 45227 https://www.medpace.com
Wuxi AppTec Co Ltd View profile 41116 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 https://www.wuxiapptec.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Canada Service - Preclinical Cro Market size, 2024 - 2033 (US$M)

Canada Preclinical CRO Market Outlook Share, 2024 & 2033 (US$M)

Canada Service - Preclinical Cro Market size, 2024 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online